InvestorsHub Logo
Followers 5
Posts 280
Boards Moderated 0
Alias Born 08/29/2015

Re: nidan7500 post# 119724

Tuesday, 09/12/2017 10:48:38 AM

Tuesday, September 12, 2017 10:48:38 AM

Post# of 459512

This from todays news suggests to me a level of organizational churn/movement/confusion/uncertainty/whatever, in BIIB. Point is, if you happen to be trying to negotiate with a company (like we think AVXL is w/BIIB) during a period of organizational churn then your plans will be in the churn along w/other things. Not a good time to try to finaize a deal



Related point today's news about FWD (forward Pharma)might be getting royalties from BIIB from Tecfideria, putting more pressure for them to get a deal together with Anavex. Yesterday's CC the CEO reiterated their desire to be the leader in Neurology space.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News